Walter Wenninger
Direttore/Membro del Consiglio presso NOXXON Pharma AG
Provenienza dei contatti di primo grado di Walter Wenninger
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
41
| Public Company | Pharmaceuticals: Major | 41 |
16
| Public Company | Pharmaceuticals: Major | 16 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.
9
| Subsidiary | Biotechnology | 9 |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.
3
| Private Company | Hospital/Nursing Management | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Walter Wenninger tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| TME PHARMA N.V. | Biotechnology | Director/Board Member Chairman Founder Chairman Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Comptroller/Controller/Auditor Corporate Officer/Principal | |
| University of Münster | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MERCK KGAA | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member President | |
| COVESTRO AG | Chemicals: Specialty | Chairman Compliance Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Bayer Pharmaceuticals Corp. | Director of Finance/CFO President Corporate Officer/Principal | ||
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Administrative Officer Sales & Marketing | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Universität zu Köln | College/University | Corporate Officer/Principal Doctorate Degree | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
AiCuris GmbH & Co. KG
 AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| University of Bristol | College/University | Undergraduate Degree Undergraduate Degree | |
RAG-Stiftung
 RAG-Stiftung Investment Trusts/Mutual FundsMiscellaneous RAG-Stiftung operates as a private foundation. It provides financing services for the perpetual mine management as well as the educational, scientific, and cultural projects related to coal mining in the Ruhr and Saar regions. The company was founded on June 26, 2007 and is headquartered in Essen, Germany. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
| Asian Institute of Management | College/University | Masters Business Admin Masters Business Admin | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| ABLYNX | Biotechnology | Chairman Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Tekniikan Akatemia -säätiö sr
 Tekniikan Akatemia -säätiö sr Investment Trusts/Mutual FundsMiscellaneous Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Deutsche Akademie der Technikwissenschaften eV
 Deutsche Akademie der Technikwissenschaften eV Miscellaneous Commercial ServicesCommercial Services Deutsche Akademie der Technikwissenschaften eV advises on technical and technological issues for engineering and applied sciences. The private company is based in Munich, Germany. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| BERTELSMANN SE & CO. KGAA | Movies/Entertainment | Director of Finance/CFO Director/Board Member | |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SYMRISE AG | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Founder Director/Board Member | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
Bayer SpA
 Bayer SpA Wholesale DistributorsDistribution Services Bayer SpA engages in the provision of human and animal health products. The company is headquartered in Milan, Italy. | Wholesale Distributors | Corporate Officer/Principal Director of Finance/CFO | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree Graduate Degree | |
Bayer Yakuhin Ltd.
 Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Bayer Yakuhin Ltd. is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The company is based in Osaka, Japan. | Pharmaceuticals: Major | Director of Finance/CFO President | |
| University of Illinois | College/University | Director/Board Member Undergraduate Degree | |
| The University of Edinburgh | College/University | Director/Board Member Doctorate Degree | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Founder Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| EON SE | Electric Utilities | Chairman Director/Board Member | |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
 Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
Bundesverband der Deutschen Industrie e.V.
 Bundesverband der Deutschen Industrie e.V. Miscellaneous Commercial ServicesCommercial Services Bundesverband der Deutschen Industrie e.V. provides information on the German industry, economy, and economic policies. The private company is based in Berlin, Germany. The German company organizes events that bring together business, politics, science, and civil society for discussions, whether virtually, in-person, or hybrid. The company was founded by Gerhard Schempp. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| LANXESS AG | Chemicals: Major Diversified | Chief Tech/Sci/R&D Officer Director/Board Member |
Statistiche
Distribuzione geografica
| Germania | 26 |
| Regno Unito | 8 |
| Stati Uniti | 7 |
| Danimarca | 4 |
| Francia | 2 |
Settori
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Process Industries | 5 |
| Miscellaneous | 3 |
Posizioni
| Director/Board Member | 445 |
| Corporate Officer/Principal | 223 |
| Chief Executive Officer | 137 |
| Chairman | 110 |
| Independent Dir/Board Member | 85 |
Contatti più connessi
| Insiders | |
|---|---|
| Claus Asbjørn Andersson | 41 |
| Frank Armstrong | 41 |
| Corey Goodman | 35 |
| Karl-Ludwig Kley | 32 |
| Bernd Metzner | 29 |
| Joseph deBethizy | 29 |
| Hubert Birner | 27 |
| Claus Tycho Bræstrup | 27 |
| Denis Lucquin | 26 |
| Colin Bond | 25 |
| Peter John Fellner | 21 |
| Olivier Litzka | 21 |
| Wolfgang Plischke | 21 |
| Neil Gibson | 20 |
| Heino von Prondzynski | 19 |
- Borsa valori
- Insiders
- Walter Wenninger
- Connessioni Società
